Table 2.
Comparison of clinical variables in the three treatment groups
| Clinical variables | Treatment group | Mean±SD | df | F | P |
|---|---|---|---|---|---|
| Age (years) | Lithium | 15.33±1.72 | 2 | 0.28 | 0.756 |
| Carbamazepine | 15.40±1.50 | ||||
| Sodium valproate | 15.70±1.75 | ||||
| Total number of past manic episode | Lithium | 0.16±0.46 | 2 | 1.71 | 0.188 |
| Carbamazepine | 0.30±0.732 | ||||
| Sodium valproate | 0.52±0.79 | ||||
| Past number of depressive episodes | Lithium | 0.26±0.44 | 2 | 0.71 | 0.491 |
| Carbamazepine | 0.20±0.41 | ||||
| Sodium valproate | 0.11±0.33 | ||||
| Duration of index episode (days) | Lithium | 48.93±54.45 | 2 | 0.44 | 0.643 |
| Carbamazepine | 34.90±36.19 | ||||
| Sodium valproate | 48.11±70.90 | ||||
| Total number of episodes (including index episode) | Lithium | 1.43±0.67 | 2 | 0.59 | 0.556 |
| Carbamazepine | 1.40±0.75 | ||||
| Sodium valproate | 1.64±0.86 |
df – Degree of freedom; P<0.05; F – ANOVA value. SD – Standard deviation